Morphine Market Players:
- Verve Health Care Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mayne Pharma Group
- Daiichi Sankyo Company Limited
- Hikma Pharmaceuticals USA
- AbbVie Inc.
- Mylan N.V.
- Sun Pharmaceutical Industries Ltd.
- Alcaliber S.A.
- Mallinckrodt Pharmaceuticals
- AstraZeneca plc
The competitive landscape of the morphine market is rapidly evolving as established key players, pharmaceutical giants and new entrants are investing in discovering novel medicines. Key players in the market are focused on developing new technologies and products catering to the stringent regulatory norms and consumer demand. These key players are adopting several strategies such as mergers and acquisitions, joint ventures, partnerships, and novel product launches to enhance their product base and strengthen their market position. Here are some key players operating in the global morphine market:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of morphine is estimated at USD 21.91 billion.
The global morphine market size was over USD 20.88 billion in 2025 and is anticipated to witness a CAGR of around 5.5%, crossing USD 35.67 billion revenue by 2035.
The North America morphine market will hold around 35% share by 2035, driven by increasing patient pool of osteoporosis, high geriatric population, and growing healthcare investments and awareness.
Key players in the market include Verve Health Care Ltd., Mayne Pharma Group, Daiichi Sankyo Company Limited, Hikma Pharmaceuticals USA, AbbVie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Alcaliber S.A., Mallinckrodt Pharmaceuticals, AstraZeneca plc.
